Nanocarrier-based topical drug delivery for the treatment of skin diseases

被引:181
作者
Gupta, Madhu [1 ]
Agrawal, Udita [1 ]
Vyas, Suresh P. [1 ,2 ]
机构
[1] Dept Pharmaceut Sci, Drug Delivery Res Lab, Sagar, MP, India
[2] Dr HS Gour Vishwavidyalaya, Dept Pharmaceut Sci, Drug Delivery Res Lab, Sagar 470003, MP, India
关键词
nanocarriers; skin; skin disorders; topical delivery; SOLID LIPID NANOPARTICLES; IN-VITRO; DERMAL DELIVERY; PERMEATION ENHANCEMENT; LIPOSOME ENCAPSULATION; DEFORMABLE LIPOSOMES; PENETRATION ENHANCER; CYPROTERONE-ACETATE; CARRIERS; VESICLES;
D O I
10.1517/17425247.2012.686490
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Skin disorders will continue to cause complications in patients. At present, there is an expansion of research into dermatologic treatment due to a critical need for new treatment options to treat skin diseases. Areas covered: The skin itself provides a natural barrier against particle penetration for topical delivery. However, it also offers a potential approach for the delivery of therapeutics, especially in diseased skin and via the openings of hair follicles. Recent innovation might be achieved in the field of dermatological treatment with improvement in the dermal localization of bioactives into the affected skin region, via novel nanocarriers that deliver the drugs directly to the target cells. After application, these nanocarriers can penetrate through the stratum corneum into viable skin and accumulate at the target site. However, noteworthy uptake does occur after damage and in certain diseased skin. Expert opinion: Skin-targeted topical delivery by means of nanosystems, in order to produce sustained release and maintain a localized effect, will result in an effective treatment of various life-threatening dermatological conditions. In addition, research continues into the interactions between novel particles, skin and skin lipid, and the influence of particle composition on drug distribution within the skin strata.
引用
收藏
页码:783 / 804
页数:22
相关论文
共 125 条
[1]   Lipid nanocapsules for dermal application: A comparative study of lipid-based versus polymer-based nanocarriers [J].
Abdel-Mottaleb, Mona M. A. ;
Neumann, Dirk ;
Lamprecht, Alf .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 79 (01) :36-42
[2]   Nanogel particulates located within diffusion cell receptor phases following topical application demonstrates uptake into and migration across skin [J].
Abu Samah, Nor ;
Williams, Nicholas ;
Heard, Charles M. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 401 (1-2) :72-78
[3]   Antipsoriatic microemulsion gel formulations for topical drug delivery of babchi oil (Psoralea corylifolia) [J].
Ali, J. ;
Akhtar, N. ;
Sultana, Y. ;
Baboota, S. ;
Ahuja, A. .
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2008, 30 (04) :277-285
[4]   Enhancement of topical delivery from biodegradable nanoparticles [J].
Alvarez-Román, R ;
Naik, A ;
Kalia, YN ;
Guy, RH ;
Fessi, H .
PHARMACEUTICAL RESEARCH, 2004, 21 (10) :1818-1825
[5]   Novel micelle formulations to increase cutaneous bioavailability of azole antifungals [J].
Bachhav, Y. G. ;
Mondon, K. ;
Kalia, Y. N. ;
Gurny, R. ;
Moeller, M. .
JOURNAL OF CONTROLLED RELEASE, 2011, 153 (02) :126-132
[6]   Advances in transcutaneous vaccine delivery: Do all ways lead to Rome? [J].
Bal, Suzanne M. ;
Ding, Zhi ;
van Riet, Elly ;
Jiskoot, Wim ;
Bouwstra, Joke A. .
JOURNAL OF CONTROLLED RELEASE, 2010, 148 (03) :266-282
[7]  
BARRY B W, 1987, P121
[8]  
Barry B.W., 1983, DERMATOLOGICAL FORMU
[9]   Novel mechanisms and devices to enable successful transdermal drug delivery [J].
Barry, BW .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (02) :101-114
[10]  
Baspinar Y, 2012, INT J PHARM, DOI org/10.1016/j.ijpharm.2012.03.040